智通财经APP获悉，11月14日，中国证监会公布《境外发行上市备案补充材料要求((2025年11月10日— 2025年11月14日)》。中国证监会国际司公示10家企业补充材料要求，其中，公示提到要求融泰药业补 充说明最近12个月内新增股东入股价格的合理性等事项。据港交所9月26日披露，广东融泰药业股份有 限公司向港交所主板递交上市申请，中信证券为其独家保荐人。 据招股书，融泰药业是中国领先的院外医药服务商，专注于数字化营销和供应链解决方案。根据弗若斯 特沙利文的资料，按2024年收入计，该公司是中国院外医药市场第四大营销和供应链解决方案提供商， 以及中国院外医药市场第一大面向个人客户的营销和供应链解决方案提供商。 中国证监会请融泰药业补充说明以下事项，请律师核查并出具明确的法律意见： 该公司自主开发了数字化精准营销体系，并整合数字化业务及数据平台与智能物流基础设施，能为制药 公司提供全流程全渠道医药销售解决方案。该公司赋能上游制药公司在广阔而高度分散的院外医药市场 中有效触达并服务终端客户，提高了市场效率与可及性，驱动院外医药流通价值链扩展。 三、请说明公司及下属公司经营范围涉及农作物种子经营、市场调查、互联 ...

Core Viewpoint - Rongtai Pharmaceutical Co., Ltd. has submitted a listing application to the Hong Kong Stock Exchange, with CITIC Securities as the sole sponsor [1] Company Overview - Rongtai Pharmaceutical is a leading provider of outpatient pharmaceutical services in China, offering digital marketing and supply chain solutions [1] - Based on projected 2024 revenue, the company ranks as the fourth largest provider of marketing and supply chain solutions in China's outpatient pharmaceutical market and the largest for individual customer-focused solutions [1] Business Model - The company sells pharmaceutical products to individual customers through B2C and O2O e-commerce platforms such as JD Health, Alibaba Health, and Meituan Medicine [1] - It provides integrated brand operation, data management, omnichannel traceability, and smart inventory management services to pharmaceutical companies [1] - Rongtai operates its own retail pharmacy brand "Yikangsi Pharmacy" as an additional sales channel and integrates commercial insurance online medical services and patient education programs [1] Sales Strategy - The company employs a sales model through outpatient retail pharmacies and grassroots medical institutions, selling pharmaceutical products to regional sales partners and then through B2B e-commerce platforms like Yaoshibang and 1Yaocheng to grassroots terminals [1] - Rongtai strategically collaborates with national and regional large chain pharmacies to supplement sales channels and build a comprehensive outpatient pharmaceutical retail network [1]